Orgenesis Announces Agreement to Acquire Koligo Therapeutics, a Leader in Personalized Cell Therapies

NEXT STORY
Synairgen plc – Interim results for the six months ended 30 June 2020
PREV STORY
MUHC Foundation launches $200M Dream Big Campaign
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Oculogica Receives FDA Marketing Authorization for EyeBOX®, the First Non-Invasive, Baseline-Free Test for Concussion

FDA Grants Marketing Authorization for EyeBOX’s Use in Children 5 and Older and Adults ...

author_avatar
NASDAQ Market News

Helsinn supported ‘70 Years of Cancer Care in China’ celebratory event in Shanghai

author_avatar
NASDAQ Market News

Olema Oncology to Participate at the Jefferies 2021 Virtual Healthcare Conference

author_avatar
NASDAQ Market News